Navigation Links
Onyx Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
Date:3/3/2009

EMERYVILLE, Calif., March 3 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Barclays Capital Global Healthcare Conference on Tuesday, March 10, at 10:45 a.m. Eastern Time. Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx-pharm.com/wt/page/event_calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through April 10, 2009.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treated(TM). The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer, and other cancers. For more information about Onyx, visit the company's website at www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
2. Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
3. MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results
4. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
5. Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals
6. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
7. Alseres Pharmaceuticals, Inc. Announces $200,000 Financing
8. Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results
9. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
10. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
11. Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... AttorneyOne.com, a recognized authority on law, update ... the FDA on Dianeal Low Calcium (2.5mEq/L) Peritoneal ... August 15, that two lots of Dianeal Low Calcium ... II), by Baxter International Inc., are recalled ... The reason for the recall is the presence of ...
(Date:8/21/2014)... MISSOULA, Mont. (PRWEB) August 21, 2014 She ... struck blind and brain injured after a surgery to correct ... “He Works All Things Together…” author Rebecca Strom-Stewart shares her ... misguided good intentions that led to a miscarriage of justice ... trudge through the tunnel of darkness and into the light,” ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Michael E. ... his Judaic roots back to the Bluff City with recent ... Jews, even those in the United States,” says friend and ... through various outreach programs, such as providing in-house for the ... with Israel by serving in the local synagogue. And to ...
(Date:8/21/2014)... Recently nominated as the Women’s Radio Network’s ... to be the man he is today. Growing up, KC ... positive look on women, respecting them as professionals and individuals. Through ... thanks to a man who he had the pleasure of working ... KC Armstrong’s name will ring a bell to most of you ...
(Date:8/20/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) ... announced Bluehost ( http://www.bluehost.com/track/seohosts ), MaxCDN, and Justhost ... high quality PHP hosting at affordable rates. , ... Hosting are unbiased and entirely independent, ensuring that ... During the recent years, web hosting industry has ...
Breaking Medicine News(10 mins):Health News:Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:The Dramatic, Uplifting Story from a Brain Injured Woman 2Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2Health News:New Reviews Of Cheap PHP Hosting Companies Unveiled By Top 10 Best SEO Hosting 2
... is better for health than clear juice where the pulp is ... absorb chemicals known to damage cells in the body //- and ... well as heart disease. ,Most consumers prefer clear ... levels of polyphenols were found to be more in juices with ...
... eggs that can be used to produce drugs like those used ... Edinburgh, Scotland have claimed to create a flock of ... create life saving drugs. ,These drugs could in ... Health Service incurs, according to them. , For disbelievers, ...
... delivered in lipid-based nanoparticles drastically reduces the number ... tumors in mice, researchers at The University of ... University of Texas Southwestern Medical Center report in ... ,Two tumor-suppressing genes given intravenously reduced cancer separately ...
... one of the most devastating conditions of older age. ... and 24 million worldwide, dementia leads //to total loss ... making it one of people’s greatest fears of aging. ... and serious complication in older individuals that often follows ...
... armored vests and other protective gear, streamlined systems ... approaches—have combined to produce significant improvement// in the ... and Afghanistan, according to a Special Editorial in ... Surgery. ,For soldiers injured in combat today, ...
... doctors in England views their future job prospects as ... in training and healthcare delivery, //reveals a survey* published ... Medical Journal. ,While the government plans to ... conditions, away from hospitals into the community, almost a ...
Cached Medicine News:Health News:No Pills Just Omelets 2Health News:Dual Gene Therapy Suppresses Lung Cancer in Preclinical Test 2Health News:Relationship Between Delirium and Dementia 2Health News:Relationship Between Delirium and Dementia 3Health News:Relationship Between Delirium and Dementia 4Health News:Advances Have Cut Combat Deaths in Iraq and Afghanistan 2Health News:One in Four Specialist Trainee Doctors 'Very Worried' About Future Job Prospects 2
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
(Date:8/20/2014)... LOS ANGELES , Aug. 20, 2014   Easy Breathe ... today announced that its " Easy Blog " - has received ... the year.   "We are thrilled that so many ... Nick Weiss , CEO of Easy Breathe. "We,re committed to making ... use Easy Blog to stay informed about sleep apnea news ...
(Date:8/20/2014)... MUMBAI , August 20, 2014 ... owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), ... studies of a novel clinical development candidate, GBR ... discovered and developed by the Glenmark Biologics Research ... . GBR 1302 is based on Glenmark,s ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3
... Response Rate and 100% Disease Control Rate Observed in ... Patients with Medullary Thyroid Cancer, CHICAGO, June ... from an ongoing phase 1 clinical trial of,XL184, a novel small ... The maximum tolerated dose (MTD) for,XL184 has been determined to be ...
... Recipients with Cancer, HERSHEY, Pa., June 1 ... cancer is challenging.,Clinicians must balance the need to ... of chemotherapeutic agents on a,patient,s immune system., ... will be,presented today at the American Transplant Congress ...
Cached Medicine Technology:Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 2Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 3Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 4Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 5Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 6Penn State Hershey Transplant Program Uses Assay to Monitor Cell-Mediated Immunity 2
This instrument measures intraocular pressure without,contacting. Alignment is performed semi-automatically....
... InfusO.R. Pump is a syringe ... in the administration of many ... procedures. It provides for the ... relaxants, and vasoactive drugs through ...
... Management System answers the day-to-day needs ... flexibility. From programming to data retrieval, ... management right where you want it. ... to help each patient become ambulatory ...
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology....
Medicine Products: